drugset / Trial / NCT04006340

Empirical vs Tailored Therapy for H. Pylori Infection

NCT04006340

RandomizedParallel-groupOpen-labelTreatment

Summary

We aimed to compare the efficacy of genotypic resistance-guided tailored therapy vs empirical therapy for eradication of Helicobacter pylori (H. pylori) infection in randomized controlled trials.

Timeline

Start
2019-01-04
Primary completion
2019-08-31
Completion
2019-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 1 g
Subject Bismuth Potassium Citrate Unknown 300 mg
Subject Clarithromycin Small molecule 500 mg
Subject Metronidazole Small molecule 500 mg
Subject Tetracycline Unknown 500 mg
Background Esomeprazole Small molecule 40 mg